510(k) Safety Summary
A. Name of Device KOQ37 bs
e Trade Name: Stellartech Coagulation System. NOV 2 9 2002
e Common Name: Electrosurgical Unit and Accessories
e Classification Name: Device, Electrosurgical Cutting and Coagulation and Accessories
(21 CFR 878.4400)
B. Predicate Devices
Stellartech Radiofrequency Generator Model K994173, 01/20/00
1025A-115 and Model 1025A-230
ArthroCare Electrosurgery System Generator K971532, 07/23/99
Valleylab Force 2 Electrosurgical Generator K921884, 12/15/92
RadioTherapeutics RF-2000 Radiofrequency K981672, 07/17/98
Generator
ArthroCare Electrosurgery System Probe K971532, 07/23/99
Ximed Balloon Electrosurgical Probe/Device K943014, 03/11/96
Boston Scientific Microvasive Gold Probe K970278, 04/11/97
Bronchus Bronchial Catheter K980046, 05/01/98 :
C.R. Bard Eliminator Balloon Dilator K940965, 05/20/94
Hobbs Medical Dilation Balloon Catheter K834413, 05/22/84
Boston Scientific Microvasive Rigiflex ABD K number unknown
Achalasia Balloon Dilator
Cc. Device Description:
The Stellartech Coagulation System consists of the following components.
e Stellartech Coagulation Generator
e Stellartech Coagulation Probe Connection Module
e Steilartech Coagulation Probe
e Optional Stellartech Footswitch.
The proximal end of the Stellartech Coagulation Probe connects to the Stellartech
Coagulation Probe Connection Module. The proximal end of the Stellartech Coagulation
Probe Connection Module cable connects to the Stellartech Coagulation Generator.
Special 510(k) Device Modification Notification, K013139.doc Page 31 of 64

D. Indicated Use
: The Stellartech Coagulation System is indicated for use in the coagulation of bleeding and
. non-bleeding sites in the gastrointestinal tract including but not limited to, the esophagus.
Indications include Esophageal Ulcers, Mallory-Weiss tears, Arteriovenous Malformations,
Angiomata, Barrett’s Esophagus, Dieulafoy Lesions, and Angiodysplasia.
E. Technical characteristics
The technological characteristics of the Stellartech Coagulation System are substantially
equivalent to those of the above listed predicate devices.
F. Summary
By virtue of design, principles of operation, materials and intended use, the Stellartech
Coagulation System is substantially equivalent to devices currently marketed in the United
States.
Special 510(k) Device Modification Notification, K013139.doc Page 32 of 64

nner oo .
if iY DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
. “Pas : : . Food and Drug Administration
. : . . : : / 9200 Corporate Boulevard
: : . C : Rockville MD 20850
- NOV29 2002 :
Stellartech Research Corporation : a SO
James R. Santos , : : :
. ' Senior Quality Engineer : SO , a
. 1346 Bordeaux Drive . oo. .
: Sunnyvale, California 94089 . , : :
“Re: K023765 ,
Trade/Device Name: Stellartech Coagulation System
Regulation Number: 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: Class II
Product Code: GE] :
Dated: November 11, 2002
Received: November 12, 2002
Dear Mr. Santos:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications for
use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce
prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that
have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic
Act (Act) that do not require approval of a premarket approval application (PMA). You may,
therefore, market the device, subject to the general controls provisions of the Act. The general
controls provisions of the Act include requirements for annual registration, listing of devices, good
manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class I] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must comply
with all the Act’s requirements, including, but not limited to: registration and listing (21 CFR Part
807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the

. "Page 2 — Mr. James R. Santos : , . Co :
“".. quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product /
radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
a This letter will allow you to begin marketing your device as described in your Section 510(k)
: premarket notification. The FDA finding of substantial equivalence of your device to.a legally .
/ marketed predicate device results in a classification for your device and thus, permits your device
- to proceed to the market. co. . oo .
. oo If ‘you desire specific advice for your device on our labeling regulation (21 CFR Part 801); please.
oe - contact the Office of Compliance ‘at (301) 594-4659. Additionally, for questions on the promotion
: and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also,
please note the regulation entitled, "Misbranding by reference to premarket notification” (21CFR
Part 807.97). Other general information on your responsibilities under the Act may be obtained
from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free
number (800) 638-2041 or (301) 443-6597 or at its Internet address
http: //www. fda.gov/cdrh/dsma/dsmamain. html
Sincerely yours,
Mutua € There
€2° Celia M. Witten, Ph.D., MD
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure

_ 510(k) NUMBER (IF KNOWN): _/O2 37 65. — |
"DEVICE NAME: — Stellartech Coagulation System ,
- INDICATIONS FOR USE: .
‘ The Stellartech Coagulation System is indicated for use in the coagulation of bleeding and
oe non-bleeding sites in the gastrointestinal tract including but not limited to, the esophagus. ,
: "Indications include Esophageal Ulcers, Mallory-Weiss tears, Arteriovenous
. Malformations, Angiomata, Barrett’s Esophagus, Dieulafoy-Lesions, and Angiodysplasia. /
. i :
(Division Sign-Off)
Division of General, Restorative
and Neurological Devices
"1(k) Number_KOZ3765
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use _{/ OR Over-The-Counter-Use
(Per 21 CFR 801.109)
Special 510(k) Device Modification Notification, K013139.doc Page 18 of 64

